Constantiam Biosciences
About:
Constantiam Biosciences is the resource for functional evidence in clinical genetics.
Website: https://www.constantiambio.com/home
Top Investors: National Institute on Aging, National Human Genome Research Institute
Description:
Constantiam Biosciences is the resource for functional evidence in clinical genetics. By offering in-depth curation, rigorous analysis, and clear presentation of data from high-throughput genetic variant studies, MAVEvidence significantly boosts productivity and saves time for professionals in the field.
Total Funding Amount:
$2.54M
Headquarters Location:
Founded Date:
2020-01-01
Contact Email:
inquiries(AT)constantiambio.com.
Founders:
Daniel Goldman, Nicholas Schafer, Norman Kuok Ong
Number of Employees:
1-10
Last Funding Date:
2024-09-19
IPO Status:
Private
Industries:
© 2025 bioDAO.ai